The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.
作者信息
Alabaster V A, Bakhle Y S
出版信息
Br J Pharmacol. 1970 Nov;40(3):582P-583P.
Abstract
摘要
相似文献
1
The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.
Br J Pharmacol. 1970 Nov;40(3):582P-583P.
2
Proceedings: The nature of the tryptamine receptor mediating spasmogen release from rat isolated lungs.
Br J Pharmacol. 1974 Mar;50(3):463P.
3
Release of spasmogens from rat isolated lungs by tryptamines.
Eur J Pharmacol. 1977 Nov 1;46(1):31-9. doi: 10.1016/0014-2999(77)90141-8.
4
Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs.
J Pharmacol Exp Ther. 1972 Nov;183(2):341-55.
5
Effects on amine oxidase of substances which antagonize 5-hydroxytryptamine more than tryptamine on the rat fundus strip.
Br J Pharmacol Chemother. 1961 Apr;16(2):153-62. doi: 10.1111/j.1476-5381.1961.tb00308.x.
6
Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatum in vitro.
Proc West Pharmacol Soc. 1980;23:167-70.
7
Tryptamine and 5-hydroxytryptamine: actions and interactions of cortical neurones in the rat.
Life Sci. 1980 Nov 17;27(20):1849-56. doi: 10.1016/0024-3205(80)90429-4.
8
Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine.
Eur J Pharmacol. 1968 Sep;4(2):135-44. doi: 10.1016/0014-2999(68)90169-6.
9
Preliminary investigations of the metabolism and pharmacological activity of beta-hydroxytryptamines in mammals.
J Pharm Pharmacol. 1976 May;28(5):424-8. doi: 10.1111/j.2042-7158.1976.tb04647.x.
10
[Biological determination of 5-hydroxytryptamine in the frog lung preparation].
Z Biol. 1969 Mar;116(3):211-5.
引用本文的文献
1
Proceedings: The nature of the tryptamine receptor mediating spasmogen release from rat isolated lungs.
Br J Pharmacol. 1974 Mar;50(3):463P.
2
Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.
Br Med J. 1973 Jan 27;1(5847):193-6. doi: 10.1136/bmj.1.5847.193.
3
Release of spasmogenic substances induced by vasoactive amines from isolated lungs.
Br J Pharmacol. 1972 Nov;46(3):543P-544P.
4
Tryptamine receptors in rat pulmonary artery.
Br J Pharmacol. 1974 Jul;51(3):459-61. doi: 10.1111/j.1476-5381.1974.tb10684.x.
5
Prostaglandin release in canine acute haemorrhagic pancreatitis.
Gut. 1976 Jan;17(1):22-6. doi: 10.1136/gut.17.1.22.
6
Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids.
Br J Pharmacol. 1978 Jan;62(1):79-89. doi: 10.1111/j.1476-5381.1978.tb07009.x.
7
Relaxant response of goat trachea to 5-hydroxy-tryptamine mediated by D-tryptamine receptors.
Br J Pharmacol. 1979 Jun;66(2):331-6. doi: 10.1111/j.1476-5381.1979.tb13684.x.
8
Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.
Agents Actions. 1976 Jul;6(4):551-7. doi: 10.1007/BF01973279.
9
Auto-modulation of release of pharmacological mediators of immediate (type I) hypersensitivity. A review.
Agents Actions. 1977 Oct;7(4):421-30. doi: 10.1007/BF01966847.
本文引用的文献
1
The effect of a serotonin antagonist (UML 491) in carcinoid disease.
Lancet. 1961 Nov 25;2(7213):1172-4. doi: 10.1016/s0140-6736(61)90846-7.
2
Slow reacting substance and related compounds.
Prog Allergy. 1962;6:539-58.
3
5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs.
Q J Exp Physiol Cogn Med Sci. 1953;38(4):255-62. doi: 10.1113/expphysiol.1953.sp001037.
4
5-hydroxytryptamine in the circulation of the dog.
Nature. 1967 Oct 28;216(5113):335-8. doi: 10.1038/216335a0.
5
Removal of 5-hydroxytryptamine by rat isolated lung.
Br J Pharmacol. 1970 Feb;38(2):440P-441P.
6
Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.
Nature. 1969 Jul 5;223(5201):29-35. doi: 10.1038/223029a0.
7
The release and fate of vaso-active hormones in the circulation.
Br J Pharmacol. 1969 Feb;35(2):209-42. doi: 10.1111/j.1476-5381.1969.tb07982.x.
Zotero 插件